DaVita Inc. (NYSE:DVA) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. lessened its position in DaVita Inc. (NYSE:DVA) by 5.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,168 shares of the company’s stock after selling 3,647 shares during the quarter. Principal Financial Group Inc. owned about 0.07% of DaVita worth $9,699,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Sei Investments Co. boosted its holdings in shares of DaVita by 21.3% during the 1st quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock worth $5,790,000 after purchasing an additional 7,371 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp lifted its holdings in DaVita by 17.7% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 97,016 shares of the company’s stock worth $13,378,000 after buying an additional 14,595 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its holdings in DaVita by 13.7% in the first quarter. O Shaughnessy Asset Management LLC now owns 20,890 shares of the company’s stock valued at $2,884,000 after purchasing an additional 2,512 shares during the period. UniSuper Management Pty Ltd increased its stake in shares of DaVita by 619.4% during the first quarter. UniSuper Management Pty Ltd now owns 7,323 shares of the company’s stock worth $1,011,000 after buying an additional 6,305 shares during the period. Finally, Bessemer Group Inc. raised its stake in DaVita by 2,335.6% in the first quarter. Bessemer Group Inc. now owns 10,741 shares of the company’s stock valued at $1,483,000 after buying an additional 10,300 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of NYSE:DVA opened at $157.41 on Tuesday. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The firm has a market capitalization of $12.91 billion, a price-to-earnings ratio of 16.98, a price-to-earnings-growth ratio of 0.90 and a beta of 0.89. DaVita Inc. has a 12 month low of $95.60 and a 12 month high of $168.50. The business’s 50 day simple moving average is $157.92 and its 200-day simple moving average is $147.72.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business had revenue of $3.26 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same period last year, the business earned $2.85 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. As a group, equities analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Insider Transactions at DaVita

In other DaVita news, CEO Javier Rodriguez sold 9,881 shares of DaVita stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $162.85, for a total transaction of $1,609,120.85. Following the transaction, the chief executive officer now directly owns 887,835 shares of the company’s stock, valued at $144,583,929.75. The trade was a 1.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Joel Ackerman sold 64,029 shares of the stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total value of $9,928,336.74. Following the completion of the sale, the chief financial officer now owns 111,481 shares of the company’s stock, valued at approximately $17,286,243.86. This represents a 36.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 156,086 shares of company stock worth $24,807,161 over the last quarter. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DVA. Barclays raised their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Truist Financial increased their target price on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. UBS Group lifted their target price on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Bank of America upped their price target on DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th. Finally, TD Cowen raised their target price on shares of DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research note on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.